Literature DB >> 10090485

Peutz-Jeghers syndrome: four novel inactivating germline mutations in the STK11 gene. Mutations in brief no. 227. Online.

R Kruse1, S Uhlhaas, C Lamberti, K M Keller, C Jackisch, J Steinhard, G Knöpfle, S Loff, W Back, M Stolte, M Jungck, P Propping, W Friedl, D E Jenne.   

Abstract

The diagnosis of Peutz-Jeghers syndrome is based on the occurrence of hamartomatous gastrointestinal polyps and perioral pigment spots. In view of the development of hamartomatous polyps in several syndromes and the variability of pigment spots in Peutz-Jeghers patients, identification of affected individuals is difficult. Recently, germline mutations in the STK11 gene have been reported as a molecular cause of Peutz-Jeghers syndrome. We present four novel inactivating mutations identified by direct sequencing of all 9 exons of the STK11 gene in 4 patients suggestive of Peutz-Jeghers syndrome: three frameshift mutations (125-137del; 474-480del; 516-517insT) and one nonsense mutation (Q220X). Our data obtained in these patients and in those reported previously emphasize the diagnostic value of histological discrimination between different types of hamartomatous polyps and of molecular analysis, particularly in cases with no family history of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090485     DOI: 10.1002/(SICI)1098-1004(1999)13:3<257::AID-HUMU15>3.0.CO;2-A

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome.

Authors:  E Volikos; J Robinson; K Aittomäki; J-P Mecklin; H Järvinen; A M Westerman; F W M de Rooji; T Vogel; G Moeslein; V Launonen; I P M Tomlinson; A R J Silver; L A Aaltonen
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

2.  Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.

Authors:  W Lim; N Hearle; B Shah; V Murday; S V Hodgson; A Lucassen; D Eccles; I Talbot; K Neale; A G Lim; J O'Donohue; A Donaldson; R C Macdonald; I D Young; M H Robinson; P W R Lee; B J Stoodley; I Tomlinson; D Alderson; A G Holbrook; S Vyas; E T Swarbrick; A A M Lewis; R K S Phillips; R S Houlston
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.